Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis

Investigational Site Number : 8040007, Zhytomyr

Investigational Site Number : 2330001, Tallinn

Investigational Site Number : 2030001, Prague

Investigational Site Number : 2030002, Praha 5 - Motol

Investigational Site Number : 7240005, Salt

Investigational Site Number : 8040003, Vinnytsia

Investigational Site Number : 7240001, Madrid

Investigational Site Number : 7240004, Murcia

Velocity Clinical Research Site Number : 8400007, Savannah

Neurology Associates, PA Site Number : 8400002, Maitland

University of South Florida Site Number : 8400009, Tampa

North Central Neurology Associates, PC Site Number : 8400005, Cullman

Neurology PC Site Number : 8400003, Knoxville

Investigational Site Number : 7240003, Seville

MDH Research LLC Site Number : 8400006, Westerville

UC Health, LLC Site Number : 8400008, Dayton

Investigational Site Number : 8040005, Dnipro

Investigational Site Number : 2030004, Hradec Králové

Investigational Site Number : 2030006, Pardubice

Investigational Site Number : 2500004, Nancy

Investigational Site Number : 8040002, Chernivtsi

Investigational Site Number : 2030003, Jihlava

Consultants In Neurology Site Number : 8400001, Northbrook

Investigational Site Number : 2030007, Brno

Investigational Site Number : 8040009, Odesa

Investigational Site Number : 2030005, Ostrava - Poruba

Investigational Site Number : 8040001, Lviv

Investigational Site Number : 8040006, Lviv

Investigational Site Number : 6430003, Moscow

Investigational Site Number : 6430005, Saint Petersburg

Investigational Site Number : 6430001, Saint Petersburg

Investigational Site Number : 6430006, Kazan'

Investigational Site Number : 6430007, Tyumen

Investigational Site Number : 1240003, Vancouver

Investigational Site Number : 1240001, Greenfield Park

Investigational Site Number : 5280001, Amsterdam

Investigational Site Number : 7240002, Barcelona